Foren & Soziale Netzwerke zur UNITEDHEALTH Aktie

 

Kursziel: 378.84 €

Kursziel: 369.155 €

Kursziel: 350.268 €

Kursziel: 357.7026 €

Kursziel: 320.0 €

Kursziel: -

- NYSE:UNH offers best risk to reward for 2026 - Increase in premium is going to kick off starting 2026 - All these revisions by analyst would be easy to beat. - NYSE:UNH has been eating up the shares when it was beaten down should also boost eps - Technically, breakout -> consolidate -> breakout is more sustainable. Good luck everyone!

Kursziel: 349.4905 €

- NYSE:UNH has nothing to do with China-US trade war because all of its business is in US. - Companies which will get hurt by China - US tensions would be MNCs ( multi national companies) , Chips related companies, Retail like clothing, beauty products and some healthcare which get raw materials from the china for drug. - Insurance related companies should do well amidst this macro development. - NYSE:UNH selling on china related trade war is so stupid and I believe it's algorithmic selling but once institutional investors and fund managers come back to senses. - They should consider parking money in NYSE:UNH for safe compounding amidst this new macro shenanigan. - NYSE:UNH is still undervalued, defensive & doesn't have any exposure to US-china trade wars. - NYSE:UNH is increasing rates for premium starting 2026 that's one more big tailwind.

Kursziel: 365.1175 €

Kursziel: 369.413 €

Kursziel: 372.4233 €

Kursziel: 344.04 €

Kursziel: 341.92 €

NYSE:UNH is currently testing its All-Time High Anchored Volume Weighted Average Price (ATH AVWAP), while simultaneously forming what appears to be a flat base. In pre-market trading today, the stock price has moved above the AVWAP, potentially indicating reduced overhead resistance and the possibility for continued upward momentum. Position and Strategy I initiated a position in NYSE:UNH on August 13th and have steadily increased my holdings up to and including yesterday. As the stock approaches a critical juncture, there is potential for it to continue rallying, especially with earnings scheduled to be announced in 25 days. Analyst Ratings and Price Targets The consensus among analysts is generally positive for NYSE:UNH , with 16 rating it as a buy or strong buy, 7 assigning a hold rating, and 3 recommending a sell. The highest 12-month price target currently stands at $440. Future Plans If NYSE:UNH can move above the $362 level, I plan to further increase my already oversized position, as this

- NYSE:UNH offers best risk to reward fundamentally for 2026. Premium increase is coming in 2026, that will boost the fundamentals and improve margins and boost revenue and free cash flow. - I'm not gonna repeat my fundamental thesis. Please see my older post. - For this post, just highlighting the technical breakout. - NYSE:UNH has been beautifully grinding higher, pulling back, consolidating and then breaking out. This is exactly you want to see as a long term investor for a compounding machine. - Breakout also helps momentum traders to ride the wave.

Kursziel: 413.0 €

Kursziel: -

Kursziel: -

Kursziel: 336.777 €